ConductScience.org, home

Paper894713

Cross-link repair in human cells and its possible defect in Fanconi's anemia cells.

Fujiwara Y and 1 other. J Mol Biol, 1977. Cited by 289 papers, by iCite.

Cite this record

ConductScience Library. Cross-link repair in human cells and its possible defect in Fanconi's anemia cells. Papers, record 894713. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/894713

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Cross-link repair in human cells and its possible defect in Fanconi's anemia cells.
PubMed
Journal
J Mol Biol
PubMed
Year
1977
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
289
iCite
Relative citation ratio, by iCite
7.79
iCite
Revised in PubMed
2019-07-10
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Fujiwara YY
2Tatsumi MM

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anemia, AplasticMajor topic
DNA RepairMajor topic
Fanconi AnemiaMajor topic
Binding Sites
Cell Survival
Chromatography
Chromosome Aberrations
Chromosome Disorders
DNA
Humans
In Vitro Techniques
Mitomycins
Radiation Effects
Ultraviolet Rays
Xeroderma Pigmentosum

Source PubMed

Download CSV of topics

Cited by49

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 289 citations.

PMIDTitleJournalYearIn PapersSource
38607080Cell Membrane Fragment-Wrapped Parenteral Nanoemulsions: A New Drug Delivery Tool to Target Gliomas.Cells2024https://conductscience.org/library/papers/38607080PubMed
30045856Limited Capacity or Involvement of Excision Repair, Double-Strand Breaks, or Translesion Synthesis for Psoralen Cross-Link Repair in Escherichia coli.Genetics2018https://conductscience.org/library/papers/30045856PubMed
24186085Interactions among genes controlling sensitivity to radiation (RAD) and to alkylation by nitrogen mustard (SNM) in yeast.Curr Genet1982https://conductscience.org/library/papers/24186085PubMed
19805513XPF-ERCC1 participates in the Fanconi anemia pathway of cross-link repair.Mol Cell Biol2009https://conductscience.org/library/papers/19805513PubMed
19622404Cellular and molecular consequences of defective Fanconi anemia proteins in replication-coupled DNA repair: mechanistic insights.Mutat Res2009https://conductscience.org/library/papers/19622404PubMed
19053323Mapping DNA adducts of mitomycin C and decarbamoyl mitomycin C in cell lines using liquid chromatography/ electrospray tandem mass spectrometry.Chem Res Toxicol2008https://conductscience.org/library/papers/19053323PubMed
15860134A novel duplication polymorphism in the FANCA promoter and its association with breast and ovarian cancer.BMC Cancer2005https://conductscience.org/library/papers/15860134PubMed
11095693Differential processing of UV mimetic and interstrand crosslink damage by XPF cell extracts.Nucleic Acids Res2000https://conductscience.org/library/papers/11095693PubMed
9372913
Initiation of DNA interstrand cross-link repair in humans: the nucleotide excision repair system makes dual incisions 5' to the cross-linked base and removes a 22- to 28-nucleotide-long damage-free strand.
Mol Cell Biol1997https://conductscience.org/library/papers/9372913PubMed
8512813
A new anticancer platinum compound, (-)-(R)-2-aminomethyl-pyrrolidine(1,1-cyclobutanedicarboxylato) platinum(II): DNA interstrand crosslinking, repair and lethal effects in normal human, Fanconi's anaemia and xeroderma pigmentosum cells.
Br J Cancer1993https://conductscience.org/library/papers/8512813PubMed
7799938Irreversible repression of DNA synthesis in Fanconi anemia cells is alleviated by the product of a novel cyclin-related gene.Mol Cell Biol1995https://conductscience.org/library/papers/7799938PubMed
7250972Reduced uptake and incorporation of 3H-thymidine in Fanconi anemia fibroblasts.Hum Genet1981https://conductscience.org/library/papers/7250972PubMed
7094199Repair of DNA interstrand crosslinks after busulphan. A possible mode of resistance.Cancer Chemother Pharmacol1982https://conductscience.org/library/papers/7094199PubMed
7021563Cancer-associated human genetic diseases with defects in DNA repair.J Cancer Res Clin Oncol1981https://conductscience.org/library/papers/7021563PubMed
7009316Isolation and characterization of pso mutants sensitive to photo-addition of psoralen derivatives in Saccharomyces cerevisiae.Genetics1980https://conductscience.org/library/papers/7009316PubMed
7006872Immunologic studies on Werner's syndrome.Clin Exp Immunol1980https://conductscience.org/library/papers/7006872PubMed
7004875Dna repair: pathways and defects.Eur J Pediatr1980https://conductscience.org/library/papers/7004875PubMed
6992563Sister chromatid exchange analysis.Am J Hum Genet1980https://conductscience.org/library/papers/6992563PubMed
6954346UV-repair is impaired in fibroblasts from patients with Fanconi's anemia.Mol Gen Genet1982https://conductscience.org/library/papers/6954346PubMed
6890942Cytogenetic toxicity of antitumor platinum compounds in Fanconi's anemia.Hum Genet1982https://conductscience.org/library/papers/6890942PubMed

See all 49 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/894713

GET https://conductscience.org/api/papers/v1/894713/cited_by?page=2